Patent ID: 11938122
Assignee: MINORYX THERAPEUTICS S.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 2:
3. The method according to claim 1, wherein the dosage form comprises a mixture of two or more of compounds of formula (1) selected from the group consisting of compound (2): (R)-5-[[4-[2-[5-(R)-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione, compound (3): (R)-5-[[4-[2-[5-(S)-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione, compound (4): (S)-5-[[4-[2-[5-(R)-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione, and compound (5): (S)-5-[[4-[2-[5-(S)-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione, or a pharmaceutically acceptable salt thereof, wherein the mixture is optically active.